PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORONAVIRUS VACCINES

$2.78M USD

Funder	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Recipient Organization	Leidos Biomedical Research, Inc.
Country	United States
Start Date	Jun 01, 2023
End Date	May 31, 2028
Duration	1,826 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10887806`

Grant Description

THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAID'S GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATE TO ADVANCE.